Sildenafil Tablet, Film Coated
Product Images NDC 62135-372
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 62135-372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Sildenafil Tablets Figure 1)
Image Description (Sildenafil Tablets Figure 2)
This text provides information on drug interactions and recommendations for dosage adjustments based on the fold change and 90% confidence interval (CI). It includes a list of drugs such as Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinylestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. Dosage adjustments are classified as no dose adjustment needed, coadministration, or not recommended. The text also mentions the lack of benefit on exercise capacity when sildenafil is added to bosentan therapy.*
Image Description (Sildenafil Tablets Figure 3)
Image Description (Sildenafil Tablets Figure 4)
Image Description (Sildenafil Tablets Figure 5)
Image Description (Sildenafil Tablets Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.